Holen Sie sich die Stockscreener-App
367.34
0.27%
0.4549
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$367.79
Offen:
$370.68
24-Stunden-Volumen:
276.74K
Relative Volume:
0.10
Marktkapitalisierung:
$198.20B
Einnahmen:
$36.74B
Nettoeinkommen (Verlust:
$7.71B
KGV:
25.81
EPS:
14.2333
Netto-Cashflow:
$8.10B
1W Leistung:
-0.20%
1M Leistung:
-0.11%
6M Leistung:
+33.43%
1J Leistung:
+17.96%
1-Tages-Spanne:
$367.61
$372.98
1-Wochen-Bereich:
$366.53
$380.14
52-Wochen-Spanne:
$261.43
$391.29
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, AZN, NVS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
367.68 | 198.26B | 36.74B | 7.71B | 8.10B | 14.23 |
|
LLY
Lilly Eli Co
|
991.21 | 872.68B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.90 | 583.29B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
222.73 | 398.49B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
AZN
Astrazeneca Plc
|
190.54 | 298.53B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
154.41 | 294.33B | 54.72B | 14.02B | 15.32B | 7.1855 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-10 | Eingeleitet | Jefferies | Hold |
| 2026-02-20 | Eingeleitet | Barclays | Equal Weight |
| 2026-01-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Fortgesetzt | UBS | Buy |
| 2025-12-05 | Hochstufung | Erste Group | Hold → Buy |
| 2025-11-24 | Fortgesetzt | Truist | Hold |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Amgen vs Sanofi – A chronology of the patent battle over Repatha and Praluent - JUVE Patent
Amgen Inc. $AMGN Shares Sold by Martingale Asset Management L P - MarketBeat
Invesco Ltd. Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Mackenzie Financial Corp - MarketBeat
Advisory Research Inc. Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Amgen and Sanofi end epic battle over Praluent and Repatha - JUVE Patent
Is It Time To Reassess Amgen (AMGN) After Its Strong 1 Year Share Price Run? - simplywall.st
Amgen: MariTide And Osteoporosis Sales Fuel The Rally (NASDAQ:AMGN) - Seeking Alpha
SevenBridge Financial Group LLC Decreases Position in Amgen Inc. $AMGN - MarketBeat
Franklin Resources Inc. Lowers Position in Amgen Inc. $AMGN - MarketBeat
Inceptionr LLC Lowers Position in Amgen Inc. $AMGN - MarketBeat
Starbucks, Amgen, CVS and Other Stocks Help This Income Fund Shine - Barron's
Amgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference - Yahoo Finance
Kepler Cheuvreux Suisse SA Makes New $5 Million Investment in Amgen Inc. $AMGN - MarketBeat
Anti Oral Mucositis Drug Market Is Booming So Rapidly | Amgen • Merck & Co. Inc. • Bristol-Myers Squibb - openPR.com
Amgen Inc. $AMGN Stock Holdings Decreased by Richard Bernstein Advisors LLC - MarketBeat
Amgen Inc. $AMGN Shares Bought by Russell Investments Group Ltd. - MarketBeat
Bank of Montreal Can Raises Stake in Amgen Inc. $AMGN - MarketBeat
Amgen further shrinking Montgomery County footprint, cutting 22 positions - The Business Journals
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained - AOL.com
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained - 24/7 Wall St.
Forecasting The Future: 15 Analyst Projections For Amgen - Benzinga
Van ECK Associates Corp Purchases 567,400 Shares of Amgen Inc. $AMGN - MarketBeat
Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe's, Qualcomm, Rivian, Strategy and More - 24/7 Wall St.
Amgen Inc. $AMGN Stock Holdings Lifted by Capital Research Global Investors - MarketBeat
Capital International Ltd. CA Has $15.75 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Capital World Investors Acquires 1,935,876 Shares of Amgen Inc. $AMGN - MarketBeat
Capital International Sarl Purchases 46,052 Shares of Amgen Inc. $AMGN - MarketBeat
Capital International Investors Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Capital International Inc. CA Increases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Boosted by Legal & General Group Plc - MarketBeat
Capital Group Investment Management PTE. LTD. Raises Stock Position in Amgen Inc. $AMGN - MarketBeat
Capital Group Private Client Services Inc. Decreases Position in Amgen Inc. $AMGN - MarketBeat
Assessing Whether Amgen (AMGN) Shares Look Mispriced After Recent Mixed Returns - Yahoo Finance
Amgen Inc. $AMGN Shares Purchased by Schroder Investment Management Group - MarketBeat
Amgen Inc.: Close to a key resistance level - marketscreener.com
Crysvita Market Is Going to Boom | Kyowa Kirin • Amgen • Sanofi • Takeda Pharmaceutical - openPR.com
Rep. David Taylor Sells Off Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
SNL mocks Amgen’s Otezla in bizarre sketch featuring Ryan Gosling - Medical Marketing and Media
Amgen Named to Forbes’ 2026 List of America’s Best Large Employers - Amgen
9 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus - Yahoo Finance
Swiss National Bank Sells 77,600 Shares of Amgen Inc. $AMGN - MarketBeat
The first KRAS drugs have been sluggish on the market. Will the next generation fare better? - Pharma Voice
Therapeutics Companies Exceed Q4 2025 Revenue Estimates, Led by Novavax and AmgenNews and Statistics - IndexBox
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks - Finviz
First Trust Advisors LP Sells 46,048 Shares of Amgen Inc. $AMGN - MarketBeat
Better Weight Loss Stock: Novo Nordisk Vs. Amgen - The Globe and Mail
Better Weight Loss Stock: Novo Nordisk Vs. Amgen - The Motley Fool
Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate - Yahoo Finance
Vinva Investment Management Ltd Increases Holdings in Amgen Inc. $AMGN - MarketBeat
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Amgen Inc-Aktie (AMGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Option Exercise |
169.19 |
54,792 |
9,270,143 |
107,119 |
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Sale |
379.12 |
54,792 |
20,772,595 |
76,618 |
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):